Kairos Pharma Ltd KAPA
News
Kairos Pharma Presents at United Scientific Group’s 11th International Conference on Cancer Research & Drug Development
Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference